Dental Applications

Alginate-based impressions are attractive as orthodontic study models for a variety of reasons. These are fast setting at room temperature, easy to prepare, and very cost effective. The mechanism of action is based upon the reaction between a soluble calcium salt and soluble alginate (usually a sodium or potassium grade material).

Alginates high in guluronic acid typically provide high gel strength impressions. Alginates high in mannuronic acid content, on the other hand, will result in a softer or “pudding like” texture.

  • Product particle sizes vary from coarser grades with good particle flow for powder products, to fine powders for non-gritty cream formulations
  • A very well tolerated, non-irritating natural-based substance
  • Forms cross-linked gels in situ by adding calcium to the formulations

 

Recommended Products:

PROTANAL® KF200FTS

PROTANAL® LF200FTS

PROTANAL® HF120RBS

PROTANAL® KF200RBS

 
 
 

Related Applications

Thumb_Excipients_AbuseDeterrence.jpg

Dow’s excipients for drug abuse deterrence applications provide tamper resistant properties.

Thumb_Excipients_APIStability.jpg

Dow offers solutions to protect APIs from environmental conditions and increase the stability of a drug’s long-term quality, efficacy and safety

yellow_capsules_shutterstock_56239201_3_Card_Layout.png

Utilizing a novel patented process (alginate) this technology provides a unique seamless, enteric, vegetarian alternative to gelatin soft capsules in one unit process for pharmaceutical and nutraceutical applications.

4.2.9_Thumb_enteric_coating.jpg

Dow’s excipients for the enteric coating of pharmaceutical tablets.

shutterstock_562215688_3_cart_Layout.png

An enteric coating resists disintegration in the low pH of the stomach and is dissolved in the neutral pH environment of the intestine

iStock-179133772.png

Suspensions are pharmaceutically stable dispersions of an insoluble or sparingly-soluble drug in a liquid vehicle, usually an aqueous solution. They can be ready-to-use or reconstitutable, where the drug is mixed with other ingredients in the dry state and reconstituted with water at the time of dispensing to the patient.

shutterstock_564214432_3_cart_Layout.png

Use of Avicel® DG dramatically increases tablet hardness, improves yields and provides good flow and a robust ribbon during the initial compaction phase

shutterstock_373422979_3_cart_Layout.png

Dow’s excipients for controlled or modified release tablet and capsule formulations.

4.2.10_Thumb_nasal_delivery.jpg

Dow’s excipients for the nasal administration of pharmaceuticals.

iStock-582280216.png

Chewable tablets as a dosage form are growing in popularity. Palatable chewable tablets offer convenience for customers, broaden the applicability of formulations to pediatric or geriatric markets, and increase patient compliance

Thumb_Excipients_RheologyModifier.jpg

Rheology modifier, dosage form, liquid dosage forms, semi-solid formulations, thickeners, topical applications, thickening agent, Dow, Dow Pharma Solutions, METHOCEL, WALOCEL

Thumb_Excipients_SolubilityEnhancement.jpg

Dow’s portfolio of solubility enhancing excipients for drug compounds with low aqueous solubility.

4.2.3_Thumb_tabelt_coating.jpg

Dow’s excipients for film tablet coatings are tough, printable, economical and highly consistent.

Thumb_Applications_TasteMasking.jpg

Dow’s excipients for taste masking applications in the oral drug delivery of tablets.

iStock-467924581.png

Topical formulations enable local delivery of a drug to a specific site of action without systemic exposure and may be creams, gels, or sprays.

Get Started

DuPont cares about your privacy. Your personal information (name, email, phone number and other contact data) will be stored in chosen customer systems primarily hosted in the United States. This information will be used by DuPont, its affiliates, partners, and selected third parties in other countries to provide you with the product or service information requested. To learn more, please visit www.privacy.dupont.com. By providing your personal information, you agree to the terms and conditions of this Privacy Statement.

 
 
 
/content/dupont/amer/us/en/nutrition-health/references/contact-us.html /content/dupont/amer/us/en/nutrition-health/references/corporate-contact-us.html /content/dupont/amer/us/en/nutrition-health/references/subscribe.html